Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 7
1995 3
1996 2
1997 6
1998 5
1999 10
2000 11
2001 14
2002 16
2003 14
2004 12
2005 14
2006 22
2007 19
2008 26
2009 22
2010 24
2011 26
2012 27
2013 23
2014 25
2015 23
2016 28
2017 36
2018 32
2019 36
2020 26
2021 25
2022 18
2023 24
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Patel SP, Othus M, Chen Y, Wright GP Jr, Yost KJ, Hyngstrom JR, Hu-Lieskovan S, Lao CD, Fecher LA, Truong TG, Eisenstein JL, Chandra S, Sosman JA, Kendra KL, Wu RC, Devoe CE, Deutsch GB, Hegde A, Khalil M, Mangla A, Reese AM, Ross MI, Poklepovic AS, Phan GQ, Onitilo AA, Yasar DG, Powers BC, Doolittle GC, In GK, Kokot N, Gibney GT, Atkins MB, Shaheen M, Warneke JA, Ikeguchi A, Najera JE, Chmielowski B, Crompton JG, Floyd JD, Hsueh E, Margolin KA, Chow WA, Grossmann KF, Dietrich E, Prieto VG, Lowe MC, Buchbinder EI, Kirkwood JM, Korde L, Moon J, Sharon E, Sondak VK, Ribas A. Patel SP, et al. Among authors: prieto vg. N Engl J Med. 2023 Mar 2;388(9):813-823. doi: 10.1056/NEJMoa2211437. N Engl J Med. 2023. PMID: 36856617 Free PMC article. Clinical Trial.
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Amaria RN, et al. Among authors: prieto vg. Nature. 2022 Nov;611(7934):155-160. doi: 10.1038/s41586-022-05368-8. Epub 2022 Oct 26. Nature. 2022. PMID: 36289334 Free PMC article. Clinical Trial.
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Among authors: prieto vg. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748 Free article.
Leukemia cutis.
Cho-Vega JH, Medeiros LJ, Prieto VG, Vega F. Cho-Vega JH, et al. Among authors: prieto vg. Am J Clin Pathol. 2008 Jan;129(1):130-42. doi: 10.1309/WYACYWF6NGM3WBRT. Am J Clin Pathol. 2008. PMID: 18089498 Review.
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Amaria RN, et al. Among authors: prieto vg. Nature. 2023 Mar;615(7953):E23. doi: 10.1038/s41586-023-05892-1. Nature. 2023. PMID: 36894629 Free PMC article. No abstract available.
Melanoma in children.
Paradela S, Fonseca E, Prieto VG. Paradela S, et al. Among authors: prieto vg. Arch Pathol Lab Med. 2011 Mar;135(3):307-16. doi: 10.5858/2009-0503-RA.1. Arch Pathol Lab Med. 2011. PMID: 21366453 Free article. Review.
Cutaneous angiosarcoma: a current update.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Shustef E, et al. Among authors: prieto vg. J Clin Pathol. 2017 Nov;70(11):917-925. doi: 10.1136/jclinpath-2017-204601. Epub 2017 Sep 15. J Clin Pathol. 2017. PMID: 28916596 Review.
Melanoma pathology reporting and staging.
Scolyer RA, Rawson RV, Gershenwald JE, Ferguson PM, Prieto VG. Scolyer RA, et al. Among authors: prieto vg. Mod Pathol. 2020 Jan;33(Suppl 1):15-24. doi: 10.1038/s41379-019-0402-x. Epub 2019 Nov 22. Mod Pathol. 2020. PMID: 31758078 Free article. Review.
Post-radiation vascular lesions of the breast.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Suster S, Prieto VG. Ronen S, et al. Among authors: prieto vg. J Cutan Pathol. 2019 Jan;46(1):52-58. doi: 10.1111/cup.13363. Epub 2018 Nov 4. J Cutan Pathol. 2019. PMID: 30251277 Review.
Sentinel Lymph Nodes in Cutaneous Melanoma.
Prieto VG. Prieto VG. Clin Lab Med. 2017 Sep;37(3):417-430. doi: 10.1016/j.cll.2017.05.002. Epub 2017 Jun 29. Clin Lab Med. 2017. PMID: 28802493 Review.
518 results